J. Kastelein
CSIRO Manufacturing(AU)
Publications by Year
Research Areas
Lipoproteins and Cardiovascular Health, Cancer, Lipids, and Metabolism, Diabetes, Cardiovascular Risks, and Lipoproteins, Cholesterol and Lipid Metabolism, Pharmacology and Obesity Treatment
Most-Cited Works
- → Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands(2001)488 cited
- → High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions(2003)240 cited
- → Triglycerides and Cardiovascular Risk(2009)136 cited
- → Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy(1998)80 cited
- → Two common mutations (D9N, N291S) in lipoprotein lipase: a cumulative analysis of their influence on plasma lipids and lipoproteins in men and women(1999)57 cited
- → Clinical, Diagnostic, and Therapeutic Aspects of Familial Hypercholesterolemia(2004)44 cited
- → Increasing high-density lipoprotein cholesterol by cholesteryl ester transfer protein-inhibition: a rocky road and lessons learned? The early demise of the dal-HEART programme(2012)29 cited
- → Familial hypercholesterolaemia(2001)19 cited
- → Impact of a budget-restrictive (Germany) versus an incentive-driven (UK) reimbursement system on LDL-goal-achievement in statin-treated patients for secondary prevention: results of DYSIS(2013)10 cited
- → SAFETY AND EFFICACY OF LY3015014, A NEW MONOCLONAL ANTIBODY TO PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 (PCSK9) WITH AN INHERENTLY LONGER DURATION OF ACTION, IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA: A RANDOMIZED, PLACEBO-CONTROLLED, DOSE-RANGING, PHASE 2 STUDY(2015)8 cited